CRISPR Therapeutics AG

38.31
-0.80 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
38.38
0.18%
After-hours: Apr 25, 2025, 05:54 PM EDT

CRISPR Therapeutics Stock Forecast

Stock Price Forecast

The 19 analysts with 12-month price forecasts for CRSP stock have an median target of 82, with a low estimate of 32 and a high estimate of 120. The median target predicts an increase of 114.04% from the current stock price of 38.31.

Target Low Average Median High
Price $32 $74.35 $82 $120
Change -16.47% 94.07% 114.04% 213.23%

Latest Analyst Insight Report

Needham has maintained a Buy rating on CRISPR Ther... Unlock content with Pro Subscription

Updated Apr 09, 2025

Rating Oct 24Nov 24Dec 24Jan 25Feb 25Apr 25
Strong Buy 000010
Buy 012271
Hold 120050
Sell 000010
Strong Sell 000000
Total 1 3 2 2 14 1

Financial Forecast this Year

Revenue This Year
58.51M
from 35M
Increased by 67.2%
Revenue Next Year
217.49M
from 58.51M
Increased by 271.7%
EPS This Year
-4.81
from -4.34
Increased by -10.8%
EPS Next Year
-4.05
from -4.81
Increased by 15.8%